Xuejia Kang
- Molecular Biology
- Biomedical Engineering top 10%
- Immunology top 10%
- Biomaterials top 5%
- Oncology
- Topics
- RNA Interference and Gene Delivery (5 papers)Immune cells in cancer (5 papers)MicroRNA in disease regulation (3 papers)
- Partner nations
- United StatesChinaIndonesia
In The Last Decade
Xuejia Kang
26 papers receiving 887 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 378
- Biomedical Engineering 286
- Immunology 241
- Biomaterials 228
- Oncology 207
Countries citing papers authored by Xuejia Kang
This map shows the geographic impact of Xuejia Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejia Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejia Kang more than expected).
Fields of papers citing papers by Xuejia Kang
This network shows the impact of papers produced by Xuejia Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejia Kang. The network helps show where Xuejia Kang may publish in the future.
Co-authorship network of co-authors of Xuejia Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Xuejia Kang. A scholar is included among the top collaborators of Xuejia Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuejia Kang. Xuejia Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 10 | |
| 7 | 9 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 4 | |
| 11 | 32 | |
| 12 | 6 | |
| 13 | 17 | |
| 14 | 8 | |
| 15 | 9 | |
| 16 | 19 | |
| 17 | 28 | |
| 18 | 78 | |
| 19 | 29 | |
| 20 | 58 |
About Xuejia Kang
Xuejia Kang is a scholar working on Physiology, Immunology and Pharmaceutical Science, having authored 28 papers that have together received 899 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Immune cells in cancer (5 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Biomaterials (228 citations), Immunology (241 citations) and Cancer Research (115 citations). Xuejia Kang has collaborated with scholars based in United States, China and Indonesia. Frequent co-authors include Yongzhuo Huang, Weimin Yin, Aihua Wu, Wenyuan Zhang, Pengfei Zhao, Qin Xu, Jinyu Wang, Yonghui Wang, Yisi Tang and Yifei Duan. Their work appears in journals such as Advanced Functional Materials, Scientific Reports and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.